Stevanato’s New Boston Technology Center to Open in September
The center will offer expertise in fill-finish optimization and analytical testing.
In September 2020, Stevanato Group, which specializes in glass containers and drug delivery systems, will open a Technology Excellence Center in Boston.
The new site will offer full-service capabilities to companies in “the cradle of biotech,” explained Paolo Patri, Stevanato’s chief technology officer, in a press release issued on June 2 2020. Initially, the center will focus on materials science, chemistry, and engineering. Its experts will perform many value-added analytical tests that focus on characterizing container closures as well as developing and optimizing fill-finish operations, Patri said.
In the next phase of the new site’s rollout, Stevanato will add customized solutions dedicated to product development and the functional testing of primary containers and drug delivery devices, Patri said. He noted that the new center has been designed so that its services can be easily integrated within local customers’ product development teams and value chains.
Source: Stevanato Group
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
